Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New understanding and treatments for hair loss are improving, but more research is needed.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Apremilast shows promise for several skin conditions but needs more research.

Gray hair can potentially be reversed, leading to new treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Apigenin, found in plants and vegetables, has many health benefits, including anti-inflammatory, antioxidant, and anticancer effects.